Our in vitro and in vivo studies reveal that FBXW2 prevents breast cancer progression by promoting Lys-48-linked polyubiquitination to direct proteasomal degradation of Moesin through the canonical SCF complex. Here, FBXW2 is linked to breast carcinoma.